Research of the domestic market of drugs for the treatment of HIV infection

Authors

DOI:

https://doi.org/10.14739/2409-2932.2023.1.272611

Keywords:

research, drug, marketing, HIV infection, antiretroviral drugs

Abstract

The aim of the research is to study the domestic market of medicines for the treatment of HIV infection to optimize the drug supply of the target group of patients.

Materials and methods. Electronic sources of information (State Register of Medicines of Ukraine, Compendium-online, Tabletki.ua) were used to achieve the goal. System-analytical, mathematical-statistical, and comparative methods of analysis were used.

Results. The study of the assortment of drugs for the treatment of HIV infection showed the heterogeneity of the specified segment of the pharmaceutical market of Ukraine: there are solid and liquid dosage forms, both original and generic. The analysis of the company structure made it possible to establish that the national market of drugs for the treatment of HIV infection was dominated by foreign manu­facturers (95.93 %), the largest share of which was pharmaceutical companies from India (67.07 %).

The competitiveness of pharmaceutical firms supplying drugs for the treatment of HIV infection was studied. It was established that the firm Janssen-Silag S.p.A., Italy, occupied the most stable position in the studied market segment. A qualitative analysis of the mentioned medicines was carried out. The most effective and rational of them were determined.

Conclusions. A study of the domestic market of drugs for the treatment of HIV infection was conducted. The assortment and brand structure of this market segment was determined. The level of competitiveness of the above-mentioned pharmaceutical companies were analyzed, and the most successful of them were identified. At the same time, it was established that domestic pharmaceutical companies supply only 4.07 % of drugs of two out of five groups according to the ATS classification to this segment of the market. In connection with this, the development of new drugs of the specified action and the development of their production in Ukraine is important.

Author Biographies

T. P. Zarichna, Zaporizhzhia State Medical University, Ukraine

PhD, Associate Professor of the Department of Management and Pharmacy Economics

T. S. Brytanova, Zaporizhzhia State Medical University, Ukraine

PhD, Teaching Assistant of the Department of Pharmaceutical, Organic and Bioorganic Chemistry

References

Public Health Center of the Ministry of Health of Ukraine. (2022). Statystyka z VIL/SNIDu [Statistics on HIV/AIDS]. https://phc.org.ua/kontrol-zakhvoryuvan/vilsnid/statistika-z-vilsnidu

United Nations Development Programme. (2022, Decemder 1). SNID i viina: yak Ukraina boretsia z VIL/SNIDom u 2022 rotsi [AIDS and war: how Ukraine is fighting HIV/AIDS in 2022]. https://www.undp.org/uk/ukraine/news/snid-i-viyna-yak-ukrayina-boretsya-z-vil/snidom-u-2022-rotsi

Ilinska, I. F. (n.d.). Populiarno pro VIL-infektsiiu [Popular about HIV-infection] Natsionalnyi instytut ftyziatrii i pulmonolohii im. V. H. Yanovskoho. [in Ukrainian]. http://www.ifp.kiev.ua/doc/people/vil-pop/vil-pop6.htm

Ministry of Health of Ukraine. (2010, July 12). Pro zatverdzhennia klinichnoho protokolu antyretrovirusnoi terapii VIL-infektsii u doroslykh ta pidlitkiv [On the approval of the clinical protocol of antiretroviral therapy of HIV infection in adults and adolescents (No. 551)]. https://zakon.rada.gov.ua/rada/show/v0551282-10#n14

Posilkina, O. V., & Demchenko, N. V. (2014). Metodolohichni i metodychni aspekty otsinky konkurentospromozhnosti farmatsevtychnykh pidpryiemstv. [Methodological and methodical aspects of pharmaceutical companies competitiveness assessment]. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, (2), 28-35. [in Ukrainian].

Bushueva, I. V., Karpova, O. I., Demchenko, V. A., & Makovik, Yu. V. (2004). Metodicheskie podkhody k opredeleniyu ustoichivosti tovarnoi i konkurentnoi pozitsii farmatsevticheskoi firmy v usloviyakh rynka i ogranichennoi roli gosudarstva [Methodological approaches to de-termining the stability of the commodity and competitive position of a pharmaceutical company in market conditions and the limited role of the state]. Zaporozhye Medical Journal, 2(1), 109-111. [in Russian].

Balabanova, L. V., Kholod, V. V., & Balabanova, I. V (2012). Marketynh pidpryiemstva [Enterprise marketing]. Kyiv: Tsentr uchbovoi literatury. [in Ukrainian].

Dmytrenko, H. A., Anufriieva, O. L., Burlaienko, T. I., & Medvid, V. V. (2016). Kvalimetriia v upravlinni: humanistychnyi kontekst [Qualimetrics in management: a humanistic context]. Kyiv: Vydavnytstvo "Ahrarna osvita". [in Ukrainian].

Kuts, V. R., Stoliarchuk, P. H., & Druziuk, V. M. (2012). Kvalimetriia [Qualimetrics]. Lviv. [in Ukrainian].

Kompendium [Compendium]. http://compendium.com.ua/

Ministry of Health of Ukraine. (n.d.). Derzhavnyi reiestr likarskykh zasobiv Ukrainy [State register of medicines of Ukraine]. http://www.drlz.kiev.ua

Tabletki.ua. [website]. https://tabletki.ua/uk/

Published

2023-03-10

How to Cite

1.
Zarichna TP, Brytanova TS. Research of the domestic market of drugs for the treatment of HIV infection. Current issues in pharmacy and medicine: science and practice [Internet]. 2023Mar.10 [cited 2024Jul.21];16(1):60-5. Available from: http://pharmed.zsmu.edu.ua/article/view/272611

Issue

Section

Original research